Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46000697BKPyvENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS10004173HBVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS10025755HBVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30001461HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30074198HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022198HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022199HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022200HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022201HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022202HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TCGA Plot Options
Drug Information
GeneMTOR
DrugBank IDDB00337
Drug NamePimecrolimus
Target IDBE0002386
UniProt IDP42345
Regulation Typepotentiator
PubMed IDs12113647
CitationsReitamo S, Remitz A, Kyllonen H, Saarikko J: Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis. Am J Clin Dermatol. 2002;3(6):381-8.
GroupsApproved; Investigational
Direct ClassificationMacrolide lactams
SMILES[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)CC(C)=C[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC
Pathways
PharmGKBPA164783790
ChEMBLCHEMBL1200686